nodes	percent_of_prediction	percent_of_DWPC	metapath
Rifaximin—CYP3A4—Budesonide—ulcerative colitis	0.148	0.256	CbGbCtD
Rifaximin—CYP3A4—Methylprednisolone—ulcerative colitis	0.0663	0.115	CbGbCtD
Rifaximin—CYP3A4—Nicotine—ulcerative colitis	0.0646	0.112	CbGbCtD
Rifaximin—CYP3A4—Cholecalciferol—ulcerative colitis	0.0579	0.1	CbGbCtD
Rifaximin—CYP3A4—Triamcinolone—ulcerative colitis	0.0502	0.0868	CbGbCtD
Rifaximin—CYP3A4—Betamethasone—ulcerative colitis	0.0431	0.0745	CbGbCtD
Rifaximin—CYP3A4—Prednisolone—ulcerative colitis	0.0425	0.0735	CbGbCtD
Rifaximin—CYP3A4—Hydrocortisone—ulcerative colitis	0.0403	0.0697	CbGbCtD
Rifaximin—CYP3A4—Prednisone—ulcerative colitis	0.0401	0.0694	CbGbCtD
Rifaximin—CYP3A4—Dexamethasone—ulcerative colitis	0.0251	0.0433	CbGbCtD
Rifaximin—NR1I2—Nuclear Receptors—NR5A2—ulcerative colitis	0.0064	0.13	CbGpPWpGaD
Rifaximin—NR1I2—Nuclear Receptor transcription pathway—NR5A2—ulcerative colitis	0.00506	0.102	CbGpPWpGaD
Rifaximin—NR1I2—Drug Induction of Bile Acid Pathway—ABCB1—ulcerative colitis	0.00425	0.0859	CbGpPWpGaD
Rifaximin—NR1I2—Drug Induction of Bile Acid Pathway—VDR—ulcerative colitis	0.00424	0.0858	CbGpPWpGaD
Rifaximin—NR1I2—Nuclear Receptors—HNF4A—ulcerative colitis	0.00358	0.0724	CbGpPWpGaD
Rifaximin—NR1I2—Nuclear Receptor transcription pathway—HNF4A—ulcerative colitis	0.00283	0.0572	CbGpPWpGaD
Rifaximin—NR1I2—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—ulcerative colitis	0.00244	0.0494	CbGpPWpGaD
Rifaximin—NR1I2—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—ulcerative colitis	0.00243	0.0493	CbGpPWpGaD
Rifaximin—NR1I2—Nuclear Receptors—VDR—ulcerative colitis	0.00223	0.0451	CbGpPWpGaD
Rifaximin—NR1I2—Generic Transcription Pathway—ZFP90—ulcerative colitis	0.0019	0.0385	CbGpPWpGaD
Rifaximin—NR1I2—Nuclear Receptor transcription pathway—VDR—ulcerative colitis	0.00176	0.0356	CbGpPWpGaD
Rifaximin—NR1I2—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—ulcerative colitis	0.0017	0.0343	CbGpPWpGaD
Rifaximin—NR1I2—Nuclear Receptors—PPARG—ulcerative colitis	0.00155	0.0314	CbGpPWpGaD
Rifaximin—NR1I2—Nuclear Receptor transcription pathway—PPARG—ulcerative colitis	0.00123	0.0248	CbGpPWpGaD
Rifaximin—NR1I2—Gene Expression—ZFP90—ulcerative colitis	0.000916	0.0185	CbGpPWpGaD
Rifaximin—CYP3A4—Codeine and Morphine Metabolism—ABCB1—ulcerative colitis	0.000898	0.0182	CbGpPWpGaD
Rifaximin—NR1I2—Generic Transcription Pathway—NR5A2—ulcerative colitis	0.000874	0.0177	CbGpPWpGaD
Rifaximin—CYP3A4—Drug Induction of Bile Acid Pathway—ABCB1—ulcerative colitis	0.000491	0.00994	CbGpPWpGaD
Rifaximin—CYP3A4—Drug Induction of Bile Acid Pathway—VDR—ulcerative colitis	0.00049	0.00992	CbGpPWpGaD
Rifaximin—NR1I2—Generic Transcription Pathway—HNF4A—ulcerative colitis	0.000488	0.00988	CbGpPWpGaD
Rifaximin—NR1I2—Generic Transcription Pathway—MAML2—ulcerative colitis	0.000476	0.00963	CbGpPWpGaD
Rifaximin—NR1I2—Gene Expression—NR5A2—ulcerative colitis	0.000421	0.00851	CbGpPWpGaD
Rifaximin—Angiopathy—Betamethasone—ulcerative colitis	0.000341	0.000915	CcSEcCtD
Rifaximin—Angiopathy—Dexamethasone—ulcerative colitis	0.000341	0.000915	CcSEcCtD
Rifaximin—Rash—Budesonide—ulcerative colitis	0.00034	0.000915	CcSEcCtD
Rifaximin—Dermatitis—Budesonide—ulcerative colitis	0.00034	0.000914	CcSEcCtD
Rifaximin—Headache—Budesonide—ulcerative colitis	0.000338	0.000909	CcSEcCtD
Rifaximin—Loss of consciousness—Hydrocortisone—ulcerative colitis	0.000336	0.000904	CcSEcCtD
Rifaximin—Ill-defined disorder—Triamcinolone—ulcerative colitis	0.000334	0.000898	CcSEcCtD
Rifaximin—Ill-defined disorder—Methylprednisolone—ulcerative colitis	0.000333	0.000896	CcSEcCtD
Rifaximin—Diarrhoea—Azathioprine—ulcerative colitis	0.00033	0.000886	CcSEcCtD
Rifaximin—Discomfort—Prednisolone—ulcerative colitis	0.000329	0.000885	CcSEcCtD
Rifaximin—Angioedema—Triamcinolone—ulcerative colitis	0.000329	0.000884	CcSEcCtD
Rifaximin—Haemoglobin—Prednisone—ulcerative colitis	0.000329	0.000883	CcSEcCtD
Rifaximin—Angioedema—Methylprednisolone—ulcerative colitis	0.000328	0.000883	CcSEcCtD
Rifaximin—Haemorrhage—Prednisone—ulcerative colitis	0.000327	0.000879	CcSEcCtD
Rifaximin—Myalgia—Hydrocortisone—ulcerative colitis	0.000326	0.000875	CcSEcCtD
Rifaximin—Malaise—Triamcinolone—ulcerative colitis	0.000325	0.000873	CcSEcCtD
Rifaximin—Malaise—Methylprednisolone—ulcerative colitis	0.000324	0.000871	CcSEcCtD
Rifaximin—Vertigo—Triamcinolone—ulcerative colitis	0.000324	0.00087	CcSEcCtD
Rifaximin—Hypersensitivity—Mesalazine—ulcerative colitis	0.000323	0.000869	CcSEcCtD
Rifaximin—Unspecified disorder of skin and subcutaneous tissue—Hydrocortisone—ulcerative colitis	0.000323	0.000869	CcSEcCtD
Rifaximin—Syncope—Triamcinolone—ulcerative colitis	0.000323	0.000868	CcSEcCtD
Rifaximin—Vertigo—Methylprednisolone—ulcerative colitis	0.000323	0.000868	CcSEcCtD
Rifaximin—Syncope—Methylprednisolone—ulcerative colitis	0.000322	0.000866	CcSEcCtD
Rifaximin—Discomfort—Hydrocortisone—ulcerative colitis	0.000322	0.000865	CcSEcCtD
Rifaximin—Nausea—Budesonide—ulcerative colitis	0.000321	0.000862	CcSEcCtD
Rifaximin—Anaphylactic shock—Prednisolone—ulcerative colitis	0.00032	0.000859	CcSEcCtD
Rifaximin—Dizziness—Azathioprine—ulcerative colitis	0.000319	0.000857	CcSEcCtD
Rifaximin—Loss of consciousness—Triamcinolone—ulcerative colitis	0.000317	0.000851	CcSEcCtD
Rifaximin—Loss of consciousness—Methylprednisolone—ulcerative colitis	0.000316	0.000849	CcSEcCtD
Rifaximin—Asthenia—Mesalazine—ulcerative colitis	0.000315	0.000847	CcSEcCtD
Rifaximin—Shock—Prednisolone—ulcerative colitis	0.000315	0.000845	CcSEcCtD
Rifaximin—Cough—Triamcinolone—ulcerative colitis	0.000314	0.000845	CcSEcCtD
Rifaximin—Anaphylactic shock—Hydrocortisone—ulcerative colitis	0.000312	0.000839	CcSEcCtD
Rifaximin—Pruritus—Mesalazine—ulcerative colitis	0.000311	0.000835	CcSEcCtD
Rifaximin—Infection—Hydrocortisone—ulcerative colitis	0.00031	0.000834	CcSEcCtD
Rifaximin—Hyperhidrosis—Prednisolone—ulcerative colitis	0.000309	0.00083	CcSEcCtD
Rifaximin—Shock—Hydrocortisone—ulcerative colitis	0.000307	0.000825	CcSEcCtD
Rifaximin—Myalgia—Triamcinolone—ulcerative colitis	0.000307	0.000824	CcSEcCtD
Rifaximin—Vomiting—Azathioprine—ulcerative colitis	0.000306	0.000824	CcSEcCtD
Rifaximin—Nervous system disorder—Hydrocortisone—ulcerative colitis	0.000306	0.000823	CcSEcCtD
Rifaximin—Arthralgia—Methylprednisolone—ulcerative colitis	0.000306	0.000822	CcSEcCtD
Rifaximin—Myalgia—Methylprednisolone—ulcerative colitis	0.000306	0.000822	CcSEcCtD
Rifaximin—NR1I2—Generic Transcription Pathway—VDR—ulcerative colitis	0.000304	0.00615	CbGpPWpGaD
Rifaximin—Rash—Azathioprine—ulcerative colitis	0.000304	0.000817	CcSEcCtD
Rifaximin—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—ulcerative colitis	0.000304	0.000817	CcSEcCtD
Rifaximin—Dermatitis—Azathioprine—ulcerative colitis	0.000304	0.000816	CcSEcCtD
Rifaximin—Flushing—Prednisone—ulcerative colitis	0.000303	0.000815	CcSEcCtD
Rifaximin—Skin disorder—Hydrocortisone—ulcerative colitis	0.000303	0.000815	CcSEcCtD
Rifaximin—Ill-defined disorder—Betamethasone—ulcerative colitis	0.000303	0.000815	CcSEcCtD
Rifaximin—Ill-defined disorder—Dexamethasone—ulcerative colitis	0.000303	0.000815	CcSEcCtD
Rifaximin—Discomfort—Triamcinolone—ulcerative colitis	0.000303	0.000814	CcSEcCtD
Rifaximin—Discomfort—Methylprednisolone—ulcerative colitis	0.000302	0.000812	CcSEcCtD
Rifaximin—Headache—Azathioprine—ulcerative colitis	0.000302	0.000811	CcSEcCtD
Rifaximin—Hyperhidrosis—Hydrocortisone—ulcerative colitis	0.000302	0.000811	CcSEcCtD
Rifaximin—Diarrhoea—Mesalazine—ulcerative colitis	0.0003	0.000807	CcSEcCtD
Rifaximin—Dry mouth—Triamcinolone—ulcerative colitis	0.0003	0.000806	CcSEcCtD
Rifaximin—Angioedema—Dexamethasone—ulcerative colitis	0.000299	0.000803	CcSEcCtD
Rifaximin—Angioedema—Betamethasone—ulcerative colitis	0.000299	0.000803	CcSEcCtD
Rifaximin—Anorexia—Hydrocortisone—ulcerative colitis	0.000298	0.0008	CcSEcCtD
Rifaximin—Angiopathy—Prednisone—ulcerative colitis	0.000297	0.000797	CcSEcCtD
Rifaximin—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—ulcerative colitis	0.000296	0.00599	CbGpPWpGaD
Rifaximin—Confusional state—Methylprednisolone—ulcerative colitis	0.000296	0.000795	CcSEcCtD
Rifaximin—Malaise—Betamethasone—ulcerative colitis	0.000295	0.000792	CcSEcCtD
Rifaximin—Malaise—Dexamethasone—ulcerative colitis	0.000295	0.000792	CcSEcCtD
Rifaximin—Anaphylactic shock—Triamcinolone—ulcerative colitis	0.000294	0.00079	CcSEcCtD
Rifaximin—Vertigo—Betamethasone—ulcerative colitis	0.000294	0.000789	CcSEcCtD
Rifaximin—Vertigo—Dexamethasone—ulcerative colitis	0.000294	0.000789	CcSEcCtD
Rifaximin—Anaphylactic shock—Methylprednisolone—ulcerative colitis	0.000293	0.000788	CcSEcCtD
Rifaximin—Syncope—Dexamethasone—ulcerative colitis	0.000293	0.000788	CcSEcCtD
Rifaximin—Syncope—Betamethasone—ulcerative colitis	0.000293	0.000788	CcSEcCtD
Rifaximin—Infection—Triamcinolone—ulcerative colitis	0.000292	0.000785	CcSEcCtD
Rifaximin—Hypotension—Hydrocortisone—ulcerative colitis	0.000292	0.000784	CcSEcCtD
Rifaximin—Infection—Methylprednisolone—ulcerative colitis	0.000291	0.000783	CcSEcCtD
Rifaximin—Dizziness—Mesalazine—ulcerative colitis	0.00029	0.00078	CcSEcCtD
Rifaximin—Shock—Triamcinolone—ulcerative colitis	0.000289	0.000777	CcSEcCtD
Rifaximin—Insomnia—Prednisolone—ulcerative colitis	0.000289	0.000777	CcSEcCtD
Rifaximin—Shock—Methylprednisolone—ulcerative colitis	0.000289	0.000776	CcSEcCtD
Rifaximin—Nervous system disorder—Methylprednisolone—ulcerative colitis	0.000288	0.000773	CcSEcCtD
Rifaximin—Loss of consciousness—Dexamethasone—ulcerative colitis	0.000287	0.000772	CcSEcCtD
Rifaximin—Loss of consciousness—Betamethasone—ulcerative colitis	0.000287	0.000772	CcSEcCtD
Rifaximin—Mental disorder—Prednisone—ulcerative colitis	0.000286	0.00077	CcSEcCtD
Rifaximin—Nausea—Azathioprine—ulcerative colitis	0.000286	0.000769	CcSEcCtD
Rifaximin—Skin disorder—Methylprednisolone—ulcerative colitis	0.000285	0.000766	CcSEcCtD
Rifaximin—Malnutrition—Prednisone—ulcerative colitis	0.000285	0.000765	CcSEcCtD
Rifaximin—Musculoskeletal discomfort—Hydrocortisone—ulcerative colitis	0.000284	0.000764	CcSEcCtD
Rifaximin—Hyperhidrosis—Triamcinolone—ulcerative colitis	0.000284	0.000764	CcSEcCtD
Rifaximin—Hyperhidrosis—Methylprednisolone—ulcerative colitis	0.000284	0.000762	CcSEcCtD
Rifaximin—Insomnia—Hydrocortisone—ulcerative colitis	0.000282	0.000759	CcSEcCtD
Rifaximin—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—ulcerative colitis	0.000282	0.00571	CbGpPWpGaD
Rifaximin—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—ulcerative colitis	0.000282	0.0057	CbGpPWpGaD
Rifaximin—Vomiting—Mesalazine—ulcerative colitis	0.000279	0.00075	CcSEcCtD
Rifaximin—Myalgia—Dexamethasone—ulcerative colitis	0.000278	0.000748	CcSEcCtD
Rifaximin—Myalgia—Betamethasone—ulcerative colitis	0.000278	0.000748	CcSEcCtD
Rifaximin—Rash—Mesalazine—ulcerative colitis	0.000277	0.000744	CcSEcCtD
Rifaximin—Dermatitis—Mesalazine—ulcerative colitis	0.000277	0.000743	CcSEcCtD
Rifaximin—Headache—Mesalazine—ulcerative colitis	0.000275	0.000739	CcSEcCtD
Rifaximin—Discomfort—Betamethasone—ulcerative colitis	0.000275	0.000739	CcSEcCtD
Rifaximin—Discomfort—Dexamethasone—ulcerative colitis	0.000275	0.000739	CcSEcCtD
Rifaximin—Hypotension—Methylprednisolone—ulcerative colitis	0.000274	0.000737	CcSEcCtD
Rifaximin—Pain—Prednisolone—ulcerative colitis	0.000273	0.000735	CcSEcCtD
Rifaximin—Decreased appetite—Hydrocortisone—ulcerative colitis	0.000271	0.000729	CcSEcCtD
Rifaximin—Gastrointestinal disorder—Hydrocortisone—ulcerative colitis	0.00027	0.000724	CcSEcCtD
Rifaximin—Fatigue—Hydrocortisone—ulcerative colitis	0.000269	0.000723	CcSEcCtD
Rifaximin—Musculoskeletal discomfort—Triamcinolone—ulcerative colitis	0.000268	0.00072	CcSEcCtD
Rifaximin—Musculoskeletal discomfort—Methylprednisolone—ulcerative colitis	0.000267	0.000718	CcSEcCtD
Rifaximin—Pain—Hydrocortisone—ulcerative colitis	0.000267	0.000717	CcSEcCtD
Rifaximin—Anaphylactic shock—Dexamethasone—ulcerative colitis	0.000267	0.000717	CcSEcCtD
Rifaximin—Anaphylactic shock—Betamethasone—ulcerative colitis	0.000267	0.000717	CcSEcCtD
Rifaximin—Insomnia—Triamcinolone—ulcerative colitis	0.000266	0.000715	CcSEcCtD
Rifaximin—Insomnia—Methylprednisolone—ulcerative colitis	0.000265	0.000713	CcSEcCtD
Rifaximin—Infection—Dexamethasone—ulcerative colitis	0.000265	0.000712	CcSEcCtD
Rifaximin—Infection—Betamethasone—ulcerative colitis	0.000265	0.000712	CcSEcCtD
Rifaximin—Ill-defined disorder—Prednisone—ulcerative colitis	0.000264	0.00071	CcSEcCtD
Rifaximin—Feeling abnormal—Prednisolone—ulcerative colitis	0.000263	0.000708	CcSEcCtD
Rifaximin—Anaemia—Prednisone—ulcerative colitis	0.000263	0.000707	CcSEcCtD
Rifaximin—Shock—Betamethasone—ulcerative colitis	0.000262	0.000705	CcSEcCtD
Rifaximin—Shock—Dexamethasone—ulcerative colitis	0.000262	0.000705	CcSEcCtD
Rifaximin—Dyspnoea—Triamcinolone—ulcerative colitis	0.000262	0.000704	CcSEcCtD
Rifaximin—Nervous system disorder—Betamethasone—ulcerative colitis	0.000262	0.000703	CcSEcCtD
Rifaximin—Nervous system disorder—Dexamethasone—ulcerative colitis	0.000262	0.000703	CcSEcCtD
Rifaximin—Nausea—Mesalazine—ulcerative colitis	0.000261	0.000701	CcSEcCtD
Rifaximin—Angioedema—Prednisone—ulcerative colitis	0.00026	0.000699	CcSEcCtD
Rifaximin—Hyperhidrosis—Betamethasone—ulcerative colitis	0.000258	0.000693	CcSEcCtD
Rifaximin—Hyperhidrosis—Dexamethasone—ulcerative colitis	0.000258	0.000693	CcSEcCtD
Rifaximin—Feeling abnormal—Hydrocortisone—ulcerative colitis	0.000257	0.000691	CcSEcCtD
Rifaximin—Malaise—Prednisone—ulcerative colitis	0.000257	0.00069	CcSEcCtD
Rifaximin—Vertigo—Prednisone—ulcerative colitis	0.000256	0.000687	CcSEcCtD
Rifaximin—Gastrointestinal pain—Hydrocortisone—ulcerative colitis	0.000255	0.000686	CcSEcCtD
Rifaximin—Syncope—Prednisone—ulcerative colitis	0.000255	0.000686	CcSEcCtD
Rifaximin—Anorexia—Dexamethasone—ulcerative colitis	0.000254	0.000683	CcSEcCtD
Rifaximin—Anorexia—Betamethasone—ulcerative colitis	0.000254	0.000683	CcSEcCtD
Rifaximin—Urticaria—Prednisolone—ulcerative colitis	0.000254	0.000682	CcSEcCtD
Rifaximin—Fatigue—Triamcinolone—ulcerative colitis	0.000253	0.000681	CcSEcCtD
Rifaximin—Fatigue—Methylprednisolone—ulcerative colitis	0.000253	0.00068	CcSEcCtD
Rifaximin—Pain—Triamcinolone—ulcerative colitis	0.000251	0.000676	CcSEcCtD
Rifaximin—Loss of consciousness—Prednisone—ulcerative colitis	0.00025	0.000672	CcSEcCtD
Rifaximin—Hypotension—Betamethasone—ulcerative colitis	0.000249	0.00067	CcSEcCtD
Rifaximin—Hypotension—Dexamethasone—ulcerative colitis	0.000249	0.00067	CcSEcCtD
Rifaximin—Urticaria—Hydrocortisone—ulcerative colitis	0.000248	0.000667	CcSEcCtD
Rifaximin—Abdominal pain—Hydrocortisone—ulcerative colitis	0.000247	0.000663	CcSEcCtD
Rifaximin—Body temperature increased—Hydrocortisone—ulcerative colitis	0.000247	0.000663	CcSEcCtD
Rifaximin—Musculoskeletal discomfort—Dexamethasone—ulcerative colitis	0.000243	0.000653	CcSEcCtD
Rifaximin—Musculoskeletal discomfort—Betamethasone—ulcerative colitis	0.000243	0.000653	CcSEcCtD
Rifaximin—Arthralgia—Prednisone—ulcerative colitis	0.000242	0.000651	CcSEcCtD
Rifaximin—Myalgia—Prednisone—ulcerative colitis	0.000242	0.000651	CcSEcCtD
Rifaximin—Feeling abnormal—Triamcinolone—ulcerative colitis	0.000242	0.000651	CcSEcCtD
Rifaximin—Feeling abnormal—Methylprednisolone—ulcerative colitis	0.000242	0.00065	CcSEcCtD
Rifaximin—Insomnia—Betamethasone—ulcerative colitis	0.000241	0.000648	CcSEcCtD
Rifaximin—Insomnia—Dexamethasone—ulcerative colitis	0.000241	0.000648	CcSEcCtD
Rifaximin—Unspecified disorder of skin and subcutaneous tissue—Prednisone—ulcerative colitis	0.000241	0.000647	CcSEcCtD
Rifaximin—Gastrointestinal pain—Methylprednisolone—ulcerative colitis	0.00024	0.000645	CcSEcCtD
Rifaximin—Discomfort—Prednisone—ulcerative colitis	0.000239	0.000643	CcSEcCtD
Rifaximin—Hypersensitivity—Prednisolone—ulcerative colitis	0.000236	0.000633	CcSEcCtD
Rifaximin—NR1I2—Gene Expression—HNF4A—ulcerative colitis	0.000235	0.00476	CbGpPWpGaD
Rifaximin—Urticaria—Triamcinolone—ulcerative colitis	0.000234	0.000628	CcSEcCtD
Rifaximin—Urticaria—Methylprednisolone—ulcerative colitis	0.000233	0.000626	CcSEcCtD
Rifaximin—Body temperature increased—Triamcinolone—ulcerative colitis	0.000232	0.000625	CcSEcCtD
Rifaximin—Anaphylactic shock—Prednisone—ulcerative colitis	0.000232	0.000624	CcSEcCtD
Rifaximin—Abdominal pain—Methylprednisolone—ulcerative colitis	0.000232	0.000623	CcSEcCtD
Rifaximin—Decreased appetite—Dexamethasone—ulcerative colitis	0.000232	0.000623	CcSEcCtD
Rifaximin—Decreased appetite—Betamethasone—ulcerative colitis	0.000232	0.000623	CcSEcCtD
Rifaximin—Infection—Prednisone—ulcerative colitis	0.000231	0.00062	CcSEcCtD
Rifaximin—Gastrointestinal disorder—Betamethasone—ulcerative colitis	0.00023	0.000619	CcSEcCtD
Rifaximin—Gastrointestinal disorder—Dexamethasone—ulcerative colitis	0.00023	0.000619	CcSEcCtD
Rifaximin—Hypersensitivity—Hydrocortisone—ulcerative colitis	0.00023	0.000618	CcSEcCtD
Rifaximin—Fatigue—Dexamethasone—ulcerative colitis	0.00023	0.000618	CcSEcCtD
Rifaximin—Fatigue—Betamethasone—ulcerative colitis	0.00023	0.000618	CcSEcCtD
Rifaximin—NR1I2—Gene Expression—MAML2—ulcerative colitis	0.000229	0.00463	CbGpPWpGaD
Rifaximin—Shock—Prednisone—ulcerative colitis	0.000229	0.000614	CcSEcCtD
Rifaximin—Pain—Betamethasone—ulcerative colitis	0.000228	0.000613	CcSEcCtD
Rifaximin—Pain—Dexamethasone—ulcerative colitis	0.000228	0.000613	CcSEcCtD
Rifaximin—Nervous system disorder—Prednisone—ulcerative colitis	0.000228	0.000612	CcSEcCtD
Rifaximin—Skin disorder—Prednisone—ulcerative colitis	0.000226	0.000606	CcSEcCtD
Rifaximin—Hyperhidrosis—Prednisone—ulcerative colitis	0.000225	0.000603	CcSEcCtD
Rifaximin—Asthenia—Hydrocortisone—ulcerative colitis	0.000224	0.000602	CcSEcCtD
Rifaximin—Anorexia—Prednisone—ulcerative colitis	0.000221	0.000595	CcSEcCtD
Rifaximin—Pruritus—Hydrocortisone—ulcerative colitis	0.000221	0.000594	CcSEcCtD
Rifaximin—Feeling abnormal—Dexamethasone—ulcerative colitis	0.00022	0.000591	CcSEcCtD
Rifaximin—Feeling abnormal—Betamethasone—ulcerative colitis	0.00022	0.000591	CcSEcCtD
Rifaximin—Gastrointestinal pain—Dexamethasone—ulcerative colitis	0.000218	0.000586	CcSEcCtD
Rifaximin—Gastrointestinal pain—Betamethasone—ulcerative colitis	0.000218	0.000586	CcSEcCtD
Rifaximin—Hypersensitivity—Triamcinolone—ulcerative colitis	0.000217	0.000582	CcSEcCtD
Rifaximin—Hypersensitivity—Methylprednisolone—ulcerative colitis	0.000216	0.000581	CcSEcCtD
Rifaximin—Diarrhoea—Hydrocortisone—ulcerative colitis	0.000214	0.000574	CcSEcCtD
Rifaximin—NR1I2—Generic Transcription Pathway—PPARG—ulcerative colitis	0.000212	0.00429	CbGpPWpGaD
Rifaximin—Urticaria—Betamethasone—ulcerative colitis	0.000212	0.000569	CcSEcCtD
Rifaximin—Urticaria—Dexamethasone—ulcerative colitis	0.000212	0.000569	CcSEcCtD
Rifaximin—Musculoskeletal discomfort—Prednisone—ulcerative colitis	0.000212	0.000569	CcSEcCtD
Rifaximin—Dizziness—Prednisolone—ulcerative colitis	0.000211	0.000568	CcSEcCtD
Rifaximin—Asthenia—Triamcinolone—ulcerative colitis	0.000211	0.000567	CcSEcCtD
Rifaximin—Body temperature increased—Betamethasone—ulcerative colitis	0.000211	0.000567	CcSEcCtD
Rifaximin—Abdominal pain—Betamethasone—ulcerative colitis	0.000211	0.000567	CcSEcCtD
Rifaximin—Abdominal pain—Dexamethasone—ulcerative colitis	0.000211	0.000567	CcSEcCtD
Rifaximin—Body temperature increased—Dexamethasone—ulcerative colitis	0.000211	0.000567	CcSEcCtD
Rifaximin—Asthenia—Methylprednisolone—ulcerative colitis	0.00021	0.000566	CcSEcCtD
Rifaximin—Insomnia—Prednisone—ulcerative colitis	0.00021	0.000565	CcSEcCtD
Rifaximin—Pruritus—Triamcinolone—ulcerative colitis	0.000208	0.000559	CcSEcCtD
Rifaximin—Pruritus—Methylprednisolone—ulcerative colitis	0.000208	0.000558	CcSEcCtD
Rifaximin—CYP3A4—Phase 1 - Functionalization of compounds—PTGS1—ulcerative colitis	0.000207	0.0042	CbGpPWpGaD
Rifaximin—Dizziness—Hydrocortisone—ulcerative colitis	0.000206	0.000555	CcSEcCtD
Rifaximin—Decreased appetite—Prednisone—ulcerative colitis	0.000202	0.000543	CcSEcCtD
Rifaximin—Rash—Prednisolone—ulcerative colitis	0.000202	0.000542	CcSEcCtD
Rifaximin—Dermatitis—Prednisolone—ulcerative colitis	0.000201	0.000541	CcSEcCtD
Rifaximin—Diarrhoea—Methylprednisolone—ulcerative colitis	0.000201	0.000539	CcSEcCtD
Rifaximin—Fatigue—Prednisone—ulcerative colitis	0.0002	0.000538	CcSEcCtD
Rifaximin—Headache—Prednisolone—ulcerative colitis	0.0002	0.000538	CcSEcCtD
Rifaximin—Constipation—Prednisone—ulcerative colitis	0.000199	0.000534	CcSEcCtD
Rifaximin—Vomiting—Hydrocortisone—ulcerative colitis	0.000199	0.000533	CcSEcCtD
Rifaximin—Rash—Hydrocortisone—ulcerative colitis	0.000197	0.000529	CcSEcCtD
Rifaximin—Dermatitis—Hydrocortisone—ulcerative colitis	0.000197	0.000529	CcSEcCtD
Rifaximin—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—ulcerative colitis	0.000196	0.00397	CbGpPWpGaD
Rifaximin—Headache—Hydrocortisone—ulcerative colitis	0.000196	0.000526	CcSEcCtD
Rifaximin—Dizziness—Triamcinolone—ulcerative colitis	0.000194	0.000522	CcSEcCtD
Rifaximin—Dizziness—Methylprednisolone—ulcerative colitis	0.000194	0.000521	CcSEcCtD
Rifaximin—Feeling abnormal—Prednisone—ulcerative colitis	0.000191	0.000514	CcSEcCtD
Rifaximin—Asthenia—Betamethasone—ulcerative colitis	0.000191	0.000514	CcSEcCtD
Rifaximin—Asthenia—Dexamethasone—ulcerative colitis	0.000191	0.000514	CcSEcCtD
Rifaximin—Gastrointestinal pain—Prednisone—ulcerative colitis	0.00019	0.00051	CcSEcCtD
Rifaximin—Nausea—Prednisolone—ulcerative colitis	0.00019	0.00051	CcSEcCtD
Rifaximin—Pruritus—Dexamethasone—ulcerative colitis	0.000189	0.000507	CcSEcCtD
Rifaximin—Pruritus—Betamethasone—ulcerative colitis	0.000189	0.000507	CcSEcCtD
Rifaximin—Vomiting—Triamcinolone—ulcerative colitis	0.000187	0.000502	CcSEcCtD
Rifaximin—Vomiting—Methylprednisolone—ulcerative colitis	0.000187	0.000501	CcSEcCtD
Rifaximin—Nausea—Hydrocortisone—ulcerative colitis	0.000185	0.000498	CcSEcCtD
Rifaximin—Rash—Triamcinolone—ulcerative colitis	0.000185	0.000498	CcSEcCtD
Rifaximin—Dermatitis—Triamcinolone—ulcerative colitis	0.000185	0.000498	CcSEcCtD
Rifaximin—Rash—Methylprednisolone—ulcerative colitis	0.000185	0.000497	CcSEcCtD
Rifaximin—Dermatitis—Methylprednisolone—ulcerative colitis	0.000185	0.000497	CcSEcCtD
Rifaximin—Urticaria—Prednisone—ulcerative colitis	0.000185	0.000496	CcSEcCtD
Rifaximin—Headache—Triamcinolone—ulcerative colitis	0.000184	0.000495	CcSEcCtD
Rifaximin—Headache—Methylprednisolone—ulcerative colitis	0.000184	0.000494	CcSEcCtD
Rifaximin—Body temperature increased—Prednisone—ulcerative colitis	0.000184	0.000493	CcSEcCtD
Rifaximin—Abdominal pain—Prednisone—ulcerative colitis	0.000184	0.000493	CcSEcCtD
Rifaximin—Diarrhoea—Betamethasone—ulcerative colitis	0.000183	0.00049	CcSEcCtD
Rifaximin—Diarrhoea—Dexamethasone—ulcerative colitis	0.000183	0.00049	CcSEcCtD
Rifaximin—Dizziness—Betamethasone—ulcerative colitis	0.000176	0.000474	CcSEcCtD
Rifaximin—Dizziness—Dexamethasone—ulcerative colitis	0.000176	0.000474	CcSEcCtD
Rifaximin—Nausea—Triamcinolone—ulcerative colitis	0.000175	0.000469	CcSEcCtD
Rifaximin—Nausea—Methylprednisolone—ulcerative colitis	0.000174	0.000468	CcSEcCtD
Rifaximin—Hypersensitivity—Prednisone—ulcerative colitis	0.000171	0.00046	CcSEcCtD
Rifaximin—Vomiting—Betamethasone—ulcerative colitis	0.00017	0.000456	CcSEcCtD
Rifaximin—Vomiting—Dexamethasone—ulcerative colitis	0.00017	0.000456	CcSEcCtD
Rifaximin—Rash—Betamethasone—ulcerative colitis	0.000168	0.000452	CcSEcCtD
Rifaximin—Rash—Dexamethasone—ulcerative colitis	0.000168	0.000452	CcSEcCtD
Rifaximin—Dermatitis—Dexamethasone—ulcerative colitis	0.000168	0.000452	CcSEcCtD
Rifaximin—Dermatitis—Betamethasone—ulcerative colitis	0.000168	0.000452	CcSEcCtD
Rifaximin—Headache—Dexamethasone—ulcerative colitis	0.000167	0.000449	CcSEcCtD
Rifaximin—Headache—Betamethasone—ulcerative colitis	0.000167	0.000449	CcSEcCtD
Rifaximin—Asthenia—Prednisone—ulcerative colitis	0.000167	0.000448	CcSEcCtD
Rifaximin—Pruritus—Prednisone—ulcerative colitis	0.000164	0.000442	CcSEcCtD
Rifaximin—Diarrhoea—Prednisone—ulcerative colitis	0.000159	0.000427	CcSEcCtD
Rifaximin—Nausea—Dexamethasone—ulcerative colitis	0.000158	0.000426	CcSEcCtD
Rifaximin—Nausea—Betamethasone—ulcerative colitis	0.000158	0.000426	CcSEcCtD
Rifaximin—Dizziness—Prednisone—ulcerative colitis	0.000154	0.000413	CcSEcCtD
Rifaximin—Vomiting—Prednisone—ulcerative colitis	0.000148	0.000397	CcSEcCtD
Rifaximin—Rash—Prednisone—ulcerative colitis	0.000146	0.000394	CcSEcCtD
Rifaximin—NR1I2—Gene Expression—VDR—ulcerative colitis	0.000146	0.00296	CbGpPWpGaD
Rifaximin—Dermatitis—Prednisone—ulcerative colitis	0.000146	0.000393	CcSEcCtD
Rifaximin—Headache—Prednisone—ulcerative colitis	0.000146	0.000391	CcSEcCtD
Rifaximin—Nausea—Prednisone—ulcerative colitis	0.000138	0.000371	CcSEcCtD
Rifaximin—CYP3A4—Biological oxidations—PTGS1—ulcerative colitis	0.00011	0.00223	CbGpPWpGaD
Rifaximin—NR1I2—Gene Expression—PPARG—ulcerative colitis	0.000102	0.00206	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—CHP1—ulcerative colitis	4.51e-05	0.000914	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—DLD—ulcerative colitis	3.9e-05	0.000789	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—PTGS1—ulcerative colitis	1.88e-05	0.000381	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—CALM3—ulcerative colitis	1.7e-05	0.000343	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—ABCB1—ulcerative colitis	1.32e-05	0.000267	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—ADCY5—ulcerative colitis	1.23e-05	0.000249	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—PPARG—ulcerative colitis	9.18e-06	0.000186	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—ALB—ulcerative colitis	8.25e-06	0.000167	CbGpPWpGaD
Rifaximin—CYP3A4—Metabolism—PTGS2—ulcerative colitis	7.22e-06	0.000146	CbGpPWpGaD
